# Zhejiang Maida Peisi Medical Technology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zhejiang-maida-peisi-medical-technology

- Industry: Medical Devices & Equipment
- Headquarters: Hangzhou, China
- Latest round: Series A (Jul 1, 2022)
- Investors on record: 5

## About

Based in Zhejiang, China, and founded in 2018, Zhejiang Maida Peisi Medical Technology Co. Ltd., aka Zhejiang Maida Peisi Medical Technology, operates as a provider of digestive system regulation and treatment solutions. In July 2022, Zhejiang Maida Peisi Medical Technology Co., Ltd, led by its CEO Jianfeng Chen, raised an amount of series A+ funding from new investor Phoenix Tree Capital Partners.


The main indications covered by its neuromodulation products include inflammatory bowel disease (IBD), diabetes mellitus, and functional gastrointestinal disorders. Its implantable neuromodulation therapy has the advantage of being safer, more economical, and easier to implement.

The firm intends to use the funds raised in July 2022 for clinical, registration, and manufacturing sales of the neuromodulation product line.

## Funding rounds

- Series A, Jul 1, 2022 — Phoenix Tree Capital Partners
- Series A, Nov 5, 2021 — Delta Capital, Beijing PINS Medical Co., Ltd.
- Angel, Nov 6, 2020 — Delta Capital, Proxima Ventures, Biohub

## Investors

- Delta Capital (https://capitalatlas.ai/funds/delta-capital) — Angel, Series A
- Proxima Ventures (https://capitalatlas.ai/funds/proxima-ventures) — Angel
- Biohub — Angel
- Beijing PINS Medical Co., Ltd. — Series A
- Phoenix Tree Capital Partners (https://capitalatlas.ai/funds/phoenix-tree-capital-partners) — Series A